Cronos Group (NASDAQ:CRON - Get Free Report)'s stock had its "sell (d+)" rating reaffirmed by investment analysts at Weiss Ratings in a note issued to investors on Wednesday,Weiss Ratings reports.
Separately, Wall Street Zen raised shares of Cronos Group from a "sell" rating to a "hold" rating in a research report on Saturday, August 30th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of "Sell".
View Our Latest Report on Cronos Group
Cronos Group Stock Up 2.3%
CRON traded up $0.06 during trading on Wednesday, reaching $2.68. 1,629,438 shares of the stock traded hands, compared to its average volume of 2,909,809. The stock has a market capitalization of $1.03 billion, a PE ratio of 53.60 and a beta of 1.12. The stock's 50-day moving average is $2.52 and its 200 day moving average is $2.13. Cronos Group has a 12 month low of $1.60 and a 12 month high of $3.16.
Cronos Group (NASDAQ:CRON - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by ($0.08). The firm had revenue of $33.46 million for the quarter, compared to the consensus estimate of $45.73 million. Cronos Group had a net margin of 14.19% and a negative return on equity of 3.78%. As a group, equities research analysts anticipate that Cronos Group will post -0.03 EPS for the current year.
Institutional Investors Weigh In On Cronos Group
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Nuveen LLC purchased a new stake in Cronos Group in the 1st quarter valued at about $341,000. Connor Clark & Lunn Investment Management Ltd. increased its stake in Cronos Group by 53.7% in the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 47,800 shares of the company's stock valued at $86,000 after buying an additional 16,700 shares during the last quarter. Mraz Amerine & Associates Inc. purchased a new stake in Cronos Group in the 2nd quarter valued at about $57,000. Aigen Investment Management LP purchased a new stake in Cronos Group in the 1st quarter valued at about $35,000. Finally, MMCAP International Inc. SPC grew its position in shares of Cronos Group by 2.9% during the 1st quarter. MMCAP International Inc. SPC now owns 1,786,382 shares of the company's stock valued at $3,233,000 after acquiring an additional 49,782 shares during the period. Hedge funds and other institutional investors own 8.71% of the company's stock.
Cronos Group Company Profile
(
Get Free Report)
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.